OncoTargets and Therapy
Volume 4, 2011 - Issue
Open access
169
Views
8
CrossRef citations to date
0
Altmetric
Review
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
Carmen Criscitiello1 Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels
, Debora Fumagalli1 Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels
, Kamal S Saini2 Breast Data Centre, Institut Jules Bordet, Brussels, Belgium
& Sherene Loi1 Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, BrusselsCorrespondence[email protected]
Pages 1-11
|
Published online: 17 Dec 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.